Cargando…
Comparing different types of statins for secondary prevention of cardio-cerebrovascular disease from a national cohort study
Statins have been recommended for use in atherosclerotic cardio-cerebrovascular disease (CCVD). The purpose of this study was to investigate the efficacy of five different types of statin in the secondary prevention of CCVD in patients. This study retrospectively designed and analyzed data from the...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906327/ https://www.ncbi.nlm.nih.gov/pubmed/33630898 http://dx.doi.org/10.1371/journal.pone.0247419 |
_version_ | 1783655265268137984 |
---|---|
author | Kim, Joungyoun Kim, Hyeong-Seop Bae, Yun-Jong Lee, Hyeong-Chul Lee, Jae-woo Kang, Hee-Taik |
author_facet | Kim, Joungyoun Kim, Hyeong-Seop Bae, Yun-Jong Lee, Hyeong-Chul Lee, Jae-woo Kang, Hee-Taik |
author_sort | Kim, Joungyoun |
collection | PubMed |
description | Statins have been recommended for use in atherosclerotic cardio-cerebrovascular disease (CCVD). The purpose of this study was to investigate the efficacy of five different types of statin in the secondary prevention of CCVD in patients. This study retrospectively designed and analyzed data from the National Health Insurance Service-National Health in Korea. Participants aged 40 to 69 years were categorized into five statin groups (atorvastatin, rosuvastatin, pitavastatin, simvastatin, and pravastatin). The primary composite outcome was defined as recurrence of CCVD or all causes of death. Cox proportional hazard regression models were adopted after stepwise adjustments for confounders to investigate the difference in efficacy among the different statins. Of the 755 final participants, 48 patients experienced primary composite outcomes. After adjustments, the hazard ratios (95% confidence intervals) for primary composite outcomes of atorvastatin, pitavastatin, and rosuvastatin groups were 0.956 (0.456–2.005), 1.347 (0.354–5.116), and 0.943 (0.317–2.803), respectively, when compared with the simvastatin group. There were no significant differences between the statins in efficacy for preventing recurrence of CCVD events and/or death in CCVD patients. |
format | Online Article Text |
id | pubmed-7906327 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-79063272021-03-03 Comparing different types of statins for secondary prevention of cardio-cerebrovascular disease from a national cohort study Kim, Joungyoun Kim, Hyeong-Seop Bae, Yun-Jong Lee, Hyeong-Chul Lee, Jae-woo Kang, Hee-Taik PLoS One Research Article Statins have been recommended for use in atherosclerotic cardio-cerebrovascular disease (CCVD). The purpose of this study was to investigate the efficacy of five different types of statin in the secondary prevention of CCVD in patients. This study retrospectively designed and analyzed data from the National Health Insurance Service-National Health in Korea. Participants aged 40 to 69 years were categorized into five statin groups (atorvastatin, rosuvastatin, pitavastatin, simvastatin, and pravastatin). The primary composite outcome was defined as recurrence of CCVD or all causes of death. Cox proportional hazard regression models were adopted after stepwise adjustments for confounders to investigate the difference in efficacy among the different statins. Of the 755 final participants, 48 patients experienced primary composite outcomes. After adjustments, the hazard ratios (95% confidence intervals) for primary composite outcomes of atorvastatin, pitavastatin, and rosuvastatin groups were 0.956 (0.456–2.005), 1.347 (0.354–5.116), and 0.943 (0.317–2.803), respectively, when compared with the simvastatin group. There were no significant differences between the statins in efficacy for preventing recurrence of CCVD events and/or death in CCVD patients. Public Library of Science 2021-02-25 /pmc/articles/PMC7906327/ /pubmed/33630898 http://dx.doi.org/10.1371/journal.pone.0247419 Text en © 2021 Kim et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Kim, Joungyoun Kim, Hyeong-Seop Bae, Yun-Jong Lee, Hyeong-Chul Lee, Jae-woo Kang, Hee-Taik Comparing different types of statins for secondary prevention of cardio-cerebrovascular disease from a national cohort study |
title | Comparing different types of statins for secondary prevention of cardio-cerebrovascular disease from a national cohort study |
title_full | Comparing different types of statins for secondary prevention of cardio-cerebrovascular disease from a national cohort study |
title_fullStr | Comparing different types of statins for secondary prevention of cardio-cerebrovascular disease from a national cohort study |
title_full_unstemmed | Comparing different types of statins for secondary prevention of cardio-cerebrovascular disease from a national cohort study |
title_short | Comparing different types of statins for secondary prevention of cardio-cerebrovascular disease from a national cohort study |
title_sort | comparing different types of statins for secondary prevention of cardio-cerebrovascular disease from a national cohort study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906327/ https://www.ncbi.nlm.nih.gov/pubmed/33630898 http://dx.doi.org/10.1371/journal.pone.0247419 |
work_keys_str_mv | AT kimjoungyoun comparingdifferenttypesofstatinsforsecondarypreventionofcardiocerebrovasculardiseasefromanationalcohortstudy AT kimhyeongseop comparingdifferenttypesofstatinsforsecondarypreventionofcardiocerebrovasculardiseasefromanationalcohortstudy AT baeyunjong comparingdifferenttypesofstatinsforsecondarypreventionofcardiocerebrovasculardiseasefromanationalcohortstudy AT leehyeongchul comparingdifferenttypesofstatinsforsecondarypreventionofcardiocerebrovasculardiseasefromanationalcohortstudy AT leejaewoo comparingdifferenttypesofstatinsforsecondarypreventionofcardiocerebrovasculardiseasefromanationalcohortstudy AT kangheetaik comparingdifferenttypesofstatinsforsecondarypreventionofcardiocerebrovasculardiseasefromanationalcohortstudy |